Recent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): a comprehensive review
about
Management of chemotherapy-induced nausea and vomiting by risk profile: role of netupitant/palonosetronThe Effectiveness of Ginger in the Prevention of Nausea and Vomiting during Pregnancy and ChemotherapyProphylactic Management of Radiation-Induced Nausea and VomitingNeurokinin-1 inhibitors in the prevention of nausea and vomiting from highly emetogenic chemotherapy: a network meta-analysisClinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment.Delayed Chemotherapy-Induced Nausea and Vomiting: Pathogenesis, Incidence, and Current ManagementSafety of an Oral Fixed Combination of Netupitant and Palonosetron (NEPA): Pooled Data From the Phase II/III Clinical Program.Cheaper Options in the Prevention of Chemotherapy-Induced Nausea and Vomiting.Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting--a systematic review of systematic reviews.Relationship between traditional Chinese medicine constitutional types with chemotherapy-induced nausea and vomiting in patients with breast cancer: an observational study.Effect of increase in duration of aprepitant consumption from 3 to 6 days on the prevention of nausea and vomiting in women receiving combination of anthracycline/cyclophosphamide chemotherapy: A randomized, crossover, clinical trial.Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: results of a randomized, double-blind phase III trial.Personalized Estimate of Chemotherapy-Induced Nausea and Vomiting: Development and External Validation of a Nomogram in Cancer Patients Receiving Highly/Moderately Emetogenic Chemotherapy.Patterns of antiemetic prophylaxis for chemotherapy-induced nausea and vomiting in ChinaDelayed nausea and vomiting from carboplatin doublet chemotherapyEfficacy of the neurokinin-1 receptor antagonist rolapitant in preventing nausea and vomiting in patients receiving carboplatin-based chemotherapy.SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016).Detection of Nausea-Like Response in Rats by Monitoring Facial Expression.Excitatory Hindbrain-Forebrain Communication Is Required for Cisplatin-Induced Anorexia and Weight Loss.Rolapitant (Varubi): A Substance P/Neurokinin-1 Receptor Antagonist for the Prevention of Chemotherapy-Induced Nausea and Vomiting.Prevention of chemotherapy-induced nausea: the role of neurokinin-1 (NK1) receptor antagonists.Is the addition of a neurokinin-1 receptor antagonist beneficial in moderately emetogenic chemotherapy?-a systematic review and meta-analysis.Defining the efficacy of neurokinin-1 receptor antagonists in controlling chemotherapy-induced nausea and vomiting in different emetogenic settings-a meta-analysis.Cost-utility and budget impact analyses of the use of NEPA for chemotherapy-induced nausea and vomiting prophylaxis in Italy.Netupitant/Palonosetron: A Review in the Prevention of Chemotherapy-Induced Nausea and Vomiting.Additive effect of rikkunshito, an herbal medicine, on chemotherapy-induced nausea, vomiting, and anorexia in uterine cervical or corpus cancer patients treated with cisplatin and paclitaxel: results of a randomized phase II study (JORTC KMP-02).Rolapitant: a pooled analysis of its efficacy and safety in the prophylaxis of chemotherapy-induced nausea and vomiting.Emerging Role of Olanzapine for Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting.Olanzapine for chemotherapy-induced nausea and vomiting: systematic review and meta-analysis.Rolapitant for the prevention of delayed nausea and vomiting over initial and repeat courses of emetogenic chemotherapy.Supportive Care in Older Adults with Cancer: Across the Continuum.2016 Updated MASCC/ESMO Consensus Recommendations: Controlling nausea and vomiting with chemotherapy of low or minimal emetic potential.Granisetron Extended-Release Injection: A Review in Chemotherapy-Induced Nausea and Vomiting.Antiemetic therapy for non-anthracycline and cyclophosphamide moderately emetogenic chemotherapy.Efficacy benefit of an NK1 receptor antagonist (NK1RA) in patients receiving carboplatin: supportive evidence with NEPA (a fixed combination of the NK1 RA, netupitant, and palonosetron) and aprepitant regimens.Hindbrain GLP-1 receptor mediation of cisplatin-induced anorexia and nausea.Recent developments in the clinical pharmacology of rolapitant: subanalyses in specific populationsLink between diet and chemotherapy related gastrointestinal side effects.Traditional herbal medicine, Rikkunshito, for chemotherapy-induced nausea and vomiting.2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients.
P2860
Q26746211-0823418C-30CF-4CF2-BBFC-C836CCE3A9E9Q26751024-9B56A2C5-8922-4B27-A5C2-DDFF5A6CD078Q26783184-04067D07-2030-491C-B909-771248347EF6Q28078513-3F5C3AE3-B2CC-4231-9435-C7D7253ECAD8Q30234688-A467B193-6C7B-471A-B118-F007AFF77EEFQ30235971-20B1C320-C857-4AB8-B464-34E7809FD3B8Q31061449-6922AE2B-8644-403E-976F-33F8004A09D5Q33866119-5C3C02F2-9B28-4718-9283-3CC1D24BD417Q35898479-E811F4E2-160B-4D50-A935-3398DC423AB2Q36187964-7AA0C189-788D-4E68-BDFA-D51634B390A8Q36357739-F2EB1402-9B80-46DF-A6F1-EA6F49C7C902Q36384479-D41B4E38-6B6F-473D-A0CF-48AA389C8AD7Q36478194-37DFF007-7F7D-4AD0-B034-54CED51DC261Q36897218-F76F71A2-93F0-4270-8C37-6F6E2697FAD6Q37176416-0DF41D55-88C4-4962-A1BB-E88A5F515C07Q37375653-301C4DFA-AE45-4608-B0D5-7235A144F97AQ37475199-782D87EA-EBE4-4E2F-BED6-CA6E05CCDA34Q37574846-A248DC8E-C61D-433C-94A9-5C3664C14841Q37592133-878646B1-0B4F-4058-82A7-AE1EA33A38D7Q37645606-2F8AD7FD-EDE0-42E4-898A-00DB5E0FAEB6Q37736060-E8757673-F311-4186-AC3A-06B691074B0EQ38598421-F3392175-9F5C-475E-ACD3-9E11BEFCFC0AQ38609969-D0588AD7-062F-4BA7-9E48-36FD6AA4F578Q38648133-963254CE-E93F-4E76-9C50-1C40660B1D62Q38650400-34F1191C-D526-4B2C-B795-74C219D09C02Q38705385-73758127-377A-41B2-B2AF-D784FDEB08FEQ38710356-46329355-854E-4CAA-9A29-C46CD97211F2Q38739169-F897F6C4-EC3D-4A24-9D91-7C1D9FACBC7FQ38786773-E4AE3FBA-9904-492C-BF85-54D1DB85903DQ38789806-6AF36F6A-E5B9-48E6-B90E-C3ECD8FA96CBQ38876363-9C8F4DD5-D34C-46B0-8E74-DDFDC37DEF8EQ38939984-9B8CCE68-6F68-4F76-BBC9-2E2AA49D2379Q39028644-9E53E16D-D33D-4729-BE94-12493F91DEC0Q39213490-74BB1844-9D6D-4C70-BCB0-525DDE3D16D8Q39662535-A83A183A-2C25-4AB8-AAC2-AAAB8132AA5CQ40368897-04745788-7AC3-4482-86DF-30C105B138F2Q41386264-EFE43E4C-0967-4584-9ABA-14210D73EAAFQ41691717-868FC60E-1CD3-4ED8-B7E4-963F675566BAQ42341398-DBE9BC6A-2799-4BBD-B5D0-D32B1F2C4165Q46355232-41CFCE28-D7BF-4054-A841-F1C8B42DCA8E
P2860
Recent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): a comprehensive review
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Recent developments in the pre ...... (CINV): a comprehensive review
@ast
Recent developments in the pre ...... (CINV): a comprehensive review
@en
Recent developments in the pre ...... (CINV): a comprehensive review
@nl
type
label
Recent developments in the pre ...... (CINV): a comprehensive review
@ast
Recent developments in the pre ...... (CINV): a comprehensive review
@en
Recent developments in the pre ...... (CINV): a comprehensive review
@nl
prefLabel
Recent developments in the pre ...... (CINV): a comprehensive review
@ast
Recent developments in the pre ...... (CINV): a comprehensive review
@en
Recent developments in the pre ...... (CINV): a comprehensive review
@nl
P2093
P2860
P3181
P356
P1433
P1476
Recent developments in the pre ...... (CINV): a comprehensive review
@en
P2093
P2860
P304
P3181
P356
10.1093/ANNONC/MDV138
P407
P577
2015-06-01T00:00:00Z